Alexion Pharmaceuticals, Inc.
ALXNDelisted Jul 21, 2021- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000899866
Alexion Pharmaceuticals, Inc. was delisted on Jul 21, 2021; its insiders filed their last Form 4 on Jul 23, 2021; 711 institutions reported holding it in 13F filings for Q2 2021, worth $39.1B in total; superinvestors Soros Fund Management and Maverick Capital held it.
13F holders, Q3 2021
Institutional positions in Alexion Pharmaceuticals, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
ALXN is no longer listed, and 13F filings after Q2 2021 list far fewer holders. See Q2 2021
- Institutional holders
- 7
- −696 vs. Q2 2021
- Shares held
- 5.80K
- −211.1M (−100.0%) vs. Q2 2021
- Total value
- $823.0K
- −$38.9B (−100.0%) vs. Q2 2021
- New holders
- 1
- 2 more added
- Sold out
- 697
- 3 more reduced
8 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALXN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 2 | $2.16M |
| Q4 2025 | 1 | $5.40K |
| Q3 2025 | 1 | $5.79K |
| Q2 2025 | 1 | $5.52K |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 1 | $924.0K |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 1 | $8.83K |
| Q3 2023 | 1 | $10.4K |
| Q2 2023 | 1 | $13.6K |
| Q1 2023 | 1 | $13.0K |
| Q4 2022 | 1 | $13.0K |
| Q3 2022 | 1 | $16.0K |
| Q2 2022 | 1 | $13.0K |
| Q1 2022 | 1 | $13.0K |
| Q4 2021 | 2 | $14.0K |
| Q3 2021 | 7 | $823.0K |
| Q2 2021 | 711 | $39.1B |
| Q1 2021 | 755 | $31.3B |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Alexion Pharmaceuticals, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Brinker Capital Investments, LLC | 2,302 | $423.0K | 0.01% | 00.0% | Unchanged |
| Neo Ivy Capital Management | 2,587 | $290.0K | 0.33% | +2,587 | New |
| TD Ameritrade Investment Management, LLC | 741 | $85.0K | 0.00% | +714+2,644.4% | Added |
| Retirement Group, LLC | 60 | $13.0K | 0.01% | +51+566.7% | Added |
| CVA Family Office, LLC | 100 | $11.0K | 0.01% | −145−59.2% | Reduced |
| Meeder Asset Management Inc | 3 | $1.00K | 0.00% | −6,396−100.0% | Reduced |
| Barclays PLC | 6 | – | – | −2,449,972−100.0% | Reduced |
| Vanguard Group Inc | 0 | $0 | 0.00% | −20,367,300−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −17,495,607−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −10,033,808−100.0% | Sold out |
| Farallon Capital Management, L.L.C. | 0 | $0 | 0.00% | −7,707,500−100.0% | Sold out |
| HBK Investments L P | 0 | $0 | 0.00% | −6,600,000−100.0% | Sold out |
| Davidson Kempner Capital Management LP | 0 | $0 | 0.00% | −5,473,378−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −5,238,014−100.0% | Sold out |
| Pentwater Capital Management LP | 0 | $0 | 0.00% | −4,933,200−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −4,829,380−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −4,428,122−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −4,404,598−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −4,145,346−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −4,029,557−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −3,248,848−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −3,147,521−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −2,788,528−100.0% | Sold out |
| Capitolis Advisors LLC | 0 | $0 | 0.00% | −2,247,287−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −2,217,236−100.0% | Sold out |
| Norges Bank | 0 | $0 | 0.00% | −1,951,561−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −1,902,026−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −1,826,157−100.0% | Sold out |
| Omni Partners US LLC | 0 | $0 | 0.00% | −1,283,115−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −1,758,060−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −1,748,795−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −1,744,843−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −1,725,693−100.0% | Sold out |
| LSV Asset Management | 0 | $0 | 0.00% | −1,710,802−100.0% | Sold out |
| PSquared Asset Management AG | 0 | $0 | 0.00% | −1,536,316−100.0% | Sold out |
| Canada Pension Plan Investment Board | 0 | $0 | 0.00% | −1,500,325−100.0% | Sold out |
| Taconic Capital Advisors LP | 0 | $0 | 0.00% | −1,481,000−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −1,429,070−100.0% | Sold out |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −1,426,193−100.0% | Sold out |
| Westchester Capital Management, LLC | 0 | $0 | 0.00% | −1,388,701−100.0% | Sold out |
| Swedbank AB | 0 | $0 | 0.00% | −1,355,389−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −1,339,811−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −1,314,023−100.0% | Sold out |
| Alliancebernstein L.P. | 0 | $0 | 0.00% | −1,254,045−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −1,241,928−100.0% | Sold out |
| Alpine Associates Management Inc. | 0 | $0 | 0.00% | −1,219,200−100.0% | Sold out |
| Glazer Capital, LLC | 0 | $0 | 0.00% | −1,205,390−100.0% | Sold out |
| Magnetar Financial LLC | 0 | $0 | 0.00% | −1,114,010−100.0% | Sold out |
| Bank of Nova Scotia | 0 | $0 | 0.00% | −1,104,245−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −1,061,176−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −1,052,026−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −1,045,496−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −1,020,985−100.0% | Sold out |
| Arrowstreet Capital, Limited Partnership | 0 | $0 | 0.00% | −1,002,319−100.0% | Sold out |
| Ruffer LLP | 0 | $0 | 0.00% | −998,268−100.0% | Sold out |
| UBS Asset Management Americas Inc | 0 | $0 | 0.00% | −996,173−100.0% | Sold out |
| California Public Employees Retirement System | 0 | $0 | 0.00% | −949,278−100.0% | Sold out |
| TIG Advisors, LLC | 0 | $0 | 0.00% | −939,232−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −907,855−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −904,290−100.0% | Sold out |
| PFM Health Sciences, LP | 0 | $0 | 0.00% | −901,441−100.0% | Sold out |
| Swiss National Bank | 0 | $0 | 0.00% | −900,881−100.0% | Sold out |
| Melqart Asset Management (UK) Ltd | 0 | $0 | 0.00% | −885,384−100.0% | Sold out |
| Capstone Investment Advisors, LLC | 0 | $0 | 0.00% | −868,549−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −839,239−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −831,958−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −781,412−100.0% | Sold out |
| Parametric Portfolio Associates LLC | 0 | $0 | 0.00% | −776,990−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −771,620−100.0% | Sold out |
| Segantii Capital Management Ltd | 0 | $0 | 0.00% | −771,618−100.0% | Sold out |
| Neuberger Berman Group LLC | 0 | $0 | 0.00% | −769,228−100.0% | Sold out |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −725,032−100.0% | Sold out |
| Sand Grove Capital Management LLP | 0 | $0 | 0.00% | −717,127−100.0% | Sold out |
| Nuveen Asset Management, LLC | 0 | $0 | 0.00% | −715,115−100.0% | Sold out |
| Carlson Capital L P | 0 | $0 | 0.00% | −679,150−100.0% | Sold out |
| Sumitomo Mitsui Trust Holdings, Inc. | 0 | $0 | 0.00% | −678,880−100.0% | Sold out |
| First Trust Advisors LP | 0 | $0 | 0.00% | −672,646−100.0% | Sold out |
| Healthcare of Ontario Pension Plan Trust Fund | 0 | $0 | 0.00% | −671,284−100.0% | Sold out |
| Sarissa Capital Management LP | 0 | $0 | 0.00% | −650,440−100.0% | Sold out |
| Boussard & Gavaudan Investment Management LLP | 0 | $0 | 0.00% | −624,427−100.0% | Sold out |
| Sculptor Capital LP | 0 | $0 | 0.00% | −580,776−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −573,820−100.0% | Sold out |
| Water Island Capital LLC | 0 | $0 | 0.00% | −571,247−100.0% | Sold out |
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −562,635−100.0% | Sold out |
| Beryl Capital Management LLC | 0 | $0 | 0.00% | −553,245−100.0% | Sold out |
| Berry Street Capital Management LLP | 0 | $0 | 0.00% | −550,000−100.0% | Sold out |
| Grantham, Mayo, Van Otterloo & Co. LLC | 0 | $0 | 0.00% | −528,033−100.0% | Sold out |
| Eaton Vance Management | 0 | $0 | 0.00% | −525,590−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −524,772−100.0% | Sold out |
| Candriam Luxembourg S.C.A. | 0 | $0 | 0.00% | −503,510−100.0% | Sold out |
| Soros Fund Management LLCSuperinvestorSoros Fund Management | 0 | $0 | 0.00% | −500,001−100.0% | Sold out |
| Scharf Investments, LLC | 0 | $0 | 0.00% | −457,897−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −454,149−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −451,615−100.0% | Sold out |
| Canyon Capital Advisors LLC | 0 | $0 | 0.00% | −450,000−100.0% | Sold out |
| Governors Lane LP | 0 | $0 | 0.00% | −441,731−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −421,197−100.0% | Sold out |
| P Schoenfeld Asset Management LP | 0 | $0 | 0.00% | −415,168−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −410,569−100.0% | Sold out |
| MUFG Securities EMEA plc | 0 | $0 | 0.00% | −406,000−100.0% | Sold out |